Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
Background: Glatiramer acetate (GA, Copaxone®) has beneficial effects on the clinical course of relapsing-remitting multiple sclerosis (RRMS). However, the exact molecular mechanisms of GA effects are only partially understood.
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
IOS Press
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835057/ |